SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about disclosure

05 May 2023 Evaluate
Lupin has informed that as approved by the Nomination and Remuneration Committee, on May 4, 2023, the Company granted stock options aggregating 13953 to employees of an overseas subsidiary of the Company, at the exercise price of 2.00 each, under Lupin Subsidiary Companies Employees Stock Option Plan 2014. Upon vesting, one stock option entitles the grantee to subscribe to one equity share of the Company of Rs 2.00 each. The vesting schedule of the options will be 25%:25%:25%:25% over four years upon completion of one year from the date of grant, which is May 4, 2023.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2377.90 -81.85 (-3.33%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×